These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 6773617
21. Distribution and relative density of p75 nerve growth factor receptors in the rat brain as a function of age and treatment with antibodies to nerve growth factor. Urschel BA, Hulsebosch CE. Brain Res; 1992 Sep 25; 591(2):223-38. PubMed ID: 1446237 [Abstract] [Full Text] [Related]
22. Intraventricular injection of antiserum to nerve growth factor delays the development of amygdaloid kindling. Funabashi T, Sasaki H, Kimura F. Brain Res; 1988 Aug 16; 458(1):132-6. PubMed ID: 3208092 [Abstract] [Full Text] [Related]
26. Influence of neonatal treatment with 6-hydroxydopa on clonidine-induced locomotor stimulation in the infant rat. Nomura Y. Jpn J Pharmacol; 1983 Oct 16; 33(5):1092-5. PubMed ID: 6316002 [No Abstract] [Full Text] [Related]
28. Developmental localization of noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment. Harston CT, Clark MB, Hardin JC, Kostrzewa RM. Dev Neurosci; 1982 Oct 16; 5(2-3):252-62. PubMed ID: 6813097 [Abstract] [Full Text] [Related]
31. Effects of localized intracerebral injections of nerve growth factor on the regenerative growth of lesioned central noradrenergic neurones. Stenevi U, Bjerre B, Björklund A, Mobley W. Brain Res; 1974 Apr 05; 69(2):217-34. PubMed ID: 4406332 [No Abstract] [Full Text] [Related]
32. Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain. Kostrzewa RM, Garey RE. J Pharmacol Exp Ther; 1976 Apr 05; 197(1):105-18. PubMed ID: 1263125 [Abstract] [Full Text] [Related]
33. Purification and characterization of Fab fragments from anti-mouse NGF polyclonal antibodies. Callegaro L, Skaper SD, Vantini G, Benvegnù D, Di Martino A, Schiavo N, Triban C, Minozzi C, Leon A. J Mol Recognit; 1990 Apr 05; 3(5-6):187-91. PubMed ID: 2096885 [Abstract] [Full Text] [Related]
34. Trans-synaptic regulation of tyrosine hydroxylase activity in a developing mouse sympathetic ganglion: effects of nerve growth factor (NGF), NGF-antiserum and pempidine. Hendry IA. Brain Res; 1973 Jun 29; 56():313-20. PubMed ID: 4146028 [No Abstract] [Full Text] [Related]
35. In vivo evidence for a hippocampal adrenergic neuronotrophic factor specifically released on septal deafferentation. Björklund A, Stenevi U. Brain Res; 1981 Dec 21; 229(2):403-28. PubMed ID: 7306819 [Abstract] [Full Text] [Related]
36. An assessment of sympathetic function in isolated tissues from mice given nerve-growth-factor antiserum and 6-hydroxydopamine. Hughes IE, Kirk JA, Kneen B, Large BJ. Br J Pharmacol; 1973 Apr 21; 47(4):748-59. PubMed ID: 4723797 [Abstract] [Full Text] [Related]
38. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain. Romero JA, Chalmers JP, Cottman K, Lytle LD, Wurtman RJ. J Pharmacol Exp Ther; 1972 Feb 21; 180(2):277-85. PubMed ID: 5010674 [No Abstract] [Full Text] [Related]
39. The influence of central chemical sympathectomy and reserpine on peripheral effects of noradrenaline and cyclic AMP dibutyrate injected into the cerebral ventricles. Brus R, Herman ZS, Dzikowski A, Zabawska J. Arch Immunol Ther Exp (Warsz); 1976 Feb 21; 24(4):537-42. PubMed ID: 187139 [Abstract] [Full Text] [Related]